Results 221 to 230 of about 17,093 (242)
Some of the next articles are maybe not open access.

Liver Injury After Invariant NKT Cell Activation by Free Alpha-galactosylceramide and Alpha-galactosylceramide-loaded Dendritic Cells.

Anticancer research, 2017
Both free alpha-galactosylceramide (αGalCer) and αGalCer-loaded dendritic cells (DCG) activate invariant natural killer T (iNKT) cells to varying degrees, with αGalCer inducing liver injury. We sought to evaluate liver injury by these two pathways.Mice were injected with αGalCer or DCG followed by analysis of serum alanine transaminase (ALT) activity ...
Hiroshi, Hasegawa   +3 more
openaire   +1 more source

Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma.

Cancer Letters, 2017
Hongyu Liu   +21 more
semanticscholar   +1 more source

IgG Antibody Response Elicited by a Fully Synthetic Two-Component Carbohydrate-Based Cancer Vaccine Candidate with α-Galactosylceramide as Built-in Adjuvant.

Organic Letters, 2017
Xu-Guang Yin   +11 more
semanticscholar   +1 more source

Galactosylceramide sulfotransferase

1997
Dietmar Schomburg, Dörte Stephan
openaire   +1 more source

Structural analysis of cerebrosides from Aspergillus fungi: the existence of galactosylceramide in A. oryzae

Biotechnology Letters, 2014
Yasushi Tani   +7 more
semanticscholar   +1 more source

The effect of alpha-galactosylceramide upon allogenic rejection

Transplantation Proceedings, 2001
K, Seino   +6 more
openaire   +2 more sources

Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

Nature Medicine, 2001
S. Sharif   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy